Effects of Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy on Serotonergic Symptoms in Newborns and Cord Blood Monoamine and Prolactin Concentrations
- 1 July 2003
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 60 (7) , 720-726
- https://doi.org/10.1001/archpsyc.60.7.720
Abstract
Research from JAMA Psychiatry — Effects of Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy on Serotonergic Symptoms in Newborns and Cord Blood Monoamine and Prolactin ConcentrationsKeywords
This publication has 22 references indexed in Scilit:
- Birth outcomes following prenatal exposure to fluoxetineBiological Psychiatry, 2000
- Delivery outcome after the use of antidepressants in early pregnancyEuropean Journal of Clinical Pharmacology, 1999
- The impact of pregnancy and puerperium on panic disorder: a review.Journal of Psychosomatic Obstetrics & Gynecology, 1999
- Pregnancy Outcome Following Maternal Use of the New Selective Serotonin Reuptake InhibitorsJAMA, 1998
- Paroxetine withdrawal syndrome in a neonateThe British Journal of Psychiatry, 1997
- Potential fluoxetine chloride (Prozac) toxicity in a newborn.Pediatrics, 1997
- Neurodevelopment of Children Exposed in Utero to Antidepressant DrugsNew England Journal of Medicine, 1997
- Birth Outcomes in Pregnant Women Taking FluoxetineNew England Journal of Medicine, 1996
- Suspected congenital sertraline dependenceThe British Journal of Psychiatry, 1995
- Onset of obsessive-compulsive disorder in pregnancyAmerican Journal of Psychiatry, 1992